CD5-mediated inhibition of TCR signaling proceeds normally in the absence of SHP-1.

PubWeight™: 0.75‹?›

🔗 View Article (PMID 27221212)

Published in Int J Mol Med on May 17, 2016

Authors

Baoxia Dong1, Ally-Khan Somani2, Paul E Love3, Xuan Zheng1, Xiequn Chen1, Jinyi Zhang2

Author Affiliations

1: Department of Haematology, Xijing Hospital, The Fourth Military Medical University, Xi'an, Shaanxi 710032, P.R. China.
2: Lunenfeld‑Tanenbaum Research Institute, Mount Sinai Hospital, Toronto, ON M5G 1X5, Canada.
3: The Laboratory of Mammalian Genes and Development, National Institute of Child Health and Human Development, National Institutes of Health, Bethesda, MD 20892, USA.

Articles cited by this

Tolerance in T-cell-receptor transgenic mice involves deletion of nonmature CD4+8+ thymocytes. Nature (1988) 11.55

Transmembrane signalling by the T cell antigen receptor. Perturbation of the T3-antigen receptor complex generates inositol phosphates and releases calcium ions from intracellular stores. J Exp Med (1985) 5.62

CD5 expression is developmentally regulated by T cell receptor (TCR) signals and TCR avidity. J Exp Med (1998) 3.82

A role for CD5 in TCR-mediated signal transduction and thymocyte selection. Science (1995) 2.84

A requirement for the Rho-family GTP exchange factor Vav in positive and negative selection of thymocytes. Immunity (1997) 2.30

The antigen receptor on a human T cell line initiates activation by increasing cytoplasmic free calcium. J Immunol (1985) 2.13

Development and physiology of Ly-1 B and its human homolog, Leu-1 B. Immunol Rev (1986) 2.12

Expression and catalytic activity of the tyrosine phosphatase PTP1C is severely impaired in motheaten and viable motheaten mice. J Exp Med (1993) 1.95

Molecular events mediating T cell activation. Adv Immunol (1990) 1.85

CD5-mediated negative regulation of antigen receptor-induced growth signals in B-1 B cells. Science (1996) 1.84

Molecular associations between the T-lymphocyte antigen receptor complex and the surface antigens CD2, CD4, or CD8 and CD5. Proc Natl Acad Sci U S A (1992) 1.83

T cell-positive selection uses self-ligand binding strength to optimize repertoire recognition of foreign antigens. Immunity (2013) 1.58

A T-cell-directed chimeric antigen receptor for the selective treatment of T-cell malignancies. Blood (2015) 1.53

Valency of CD3 binding and internalization of the CD3 cell-surface complex control T cell responses to second signals: distinction between effects on protein kinase C, cytoplasmic free calcium, and proliferation. J Immunol (1986) 1.52

SHP-1 regulates Lck-induced phosphatidylinositol 3-kinase phosphorylation and activity. J Biol Chem (1999) 1.48

Inhibitory receptors, ITIM sequences and phosphatases. Curr Opin Immunol (1997) 1.41

CD5 negatively regulates the T-cell antigen receptor signal transduction pathway: involvement of SH2-containing phosphotyrosine phosphatase SHP-1. Mol Cell Biol (1999) 1.37

Signaling capacity of the T cell antigen receptor is negatively regulated by the PTP1C tyrosine phosphatase. J Exp Med (1996) 1.34

CD5 antibodies increase intracellular ionized calcium concentration in T cells. J Immunol (1987) 1.24

Several different cell surface molecules control negative selection of medullary thymocytes. J Exp Med (1999) 1.22

Negative regulation of CD4 lineage development and responses by CD5. J Immunol (1999) 1.20

The conserved scavenger receptor cysteine-rich superfamily in therapy and diagnosis. Pharmacol Rev (2011) 1.19

TCR signaling thresholds regulating T cell development and activation are dependent upon SHP-1. J Immunol (1999) 1.13

Ligation of the CD5 or CD28 molecules on resting human T cells induces expression of the early activation antigen CD69 by a calcium- and tyrosine kinase-dependent mechanism. Immunology (1993) 1.10

Multiple mechanisms of immune suppression by B lymphocytes. Mol Med (2012) 1.08

Negative regulation of antigen receptor-mediated signaling by constitutive association of CD5 with the SHP-1 protein tyrosine phosphatase in B-1 B cells. Eur J Immunol (1999) 1.06

Induction of human T cell proliferation by a monoclonal antibody to CD5. J Immunol (1991) 1.05

Intracellular events involved in CD5-induced human T cell activation and proliferation. J Immunol (1992) 1.03

Impaired IL-4 and c-Maf expression and enhanced Th1-cell development in Vav1-deficient mice. Blood (2005) 1.01

Differential effects of zeta and eta transgenes on early alpha/beta T cell development. J Exp Med (1994) 1.00

Chronic exposure to low levels of antigen in the periphery causes reversible functional impairment correlating with changes in CD5 levels in monoclonal CD8 T cells. J Immunol (2003) 0.99

Functional competency of T cell antigen receptors in human thymus. J Immunol (1987) 0.97

Involvement of the SHP-1 tyrosine phosphatase in regulation of T cell selection. J Immunol (1999) 0.97

Quantitative phosphoproteomic analysis of T cell receptor signaling in diabetes prone and resistant mice. J Proteome Res (2010) 0.96

Evidence for an association between the T cell receptor/CD3 antigen complex and the CD5 antigen in human T lymphocytes. Eur J Immunol (1992) 0.95

Lyn-mediated SHP-1 recruitment to CD5 contributes to resistance to apoptosis of B-cell chronic lymphocytic leukemia cells. Leukemia (2011) 0.94

CD5 expression promotes multiple intracellular signaling pathways in B lymphocyte. Autoimmun Rev (2012) 0.94

B cell receptor directs the activation of NFAT and NF-kappaB via distinct molecular mechanisms. Exp Cell Res (2003) 0.93

CD5, an important regulator of lymphocyte selection and immune tolerance. Immunol Res (2002) 0.92

Negative regulation of B cell receptor-mediated signaling in B-1 cells through CD5 and Ly49 co-receptors via Lyn kinase activity. Int Immunol (2000) 0.92

The pseudo-immunoreceptor tyrosine-based activation motif of CD5 mediates its inhibitory action on B-cell receptor signaling. J Biol Chem (2000) 0.91

Interleukin-4 (IL-4) induces phosphatidylinositol 3-kinase (p85) dephosphorylation. Implications for the role of SHP-1 in the IL-4-induced signals in human B cells. J Biol Chem (1997) 0.87

Thymocyte activation induces the association of phosphatidylinositol 3-kinase and pp120 with CD5. Eur J Immunol (1997) 0.86

CD2 and CD3 associate independently with CD5 and differentially regulate signaling through CD5 in Jurkat T cells. J Immunol (1999) 0.83

Thymocyte activation induces the association of the proto-oncoprotein c-cbl and ras GTPase-activating protein with CD5. Eur J Immunol (1998) 0.83

Thiorphan-induced survival and proliferation of rat thymocytes by activation of Akt/survivin pathway and inhibition of caspase-3 activity. J Pharmacol Exp Ther (2008) 0.83

Cutting edge: thymic selection and autoreactivity are regulated by multiple coreceptors involved in T cell activation. J Immunol (1999) 0.82

Signaling through CD5 involves acidic sphingomyelinase, protein kinase C-zeta, mitogen-activated protein kinase kinase, and c-Jun NH2-terminal kinase. J Immunol (1999) 0.81

CD1d(hi)CD5+ B cells expanded by GM-CSF in vivo suppress experimental autoimmune myasthenia gravis. J Immunol (2014) 0.81

A potential role for B cells in suppressed immune responses in cord blood transplant recipients. Bone Marrow Transplant (2012) 0.81

The human CD5L/AIM-CD36 axis: A novel autophagy inducer in macrophages that modulates inflammatory responses. Autophagy (2015) 0.79

CD5 and other superantigens may select and maintain rabbit self-renewing B-lymphocytes and human B-CLL cells. Curr Top Microbiol Immunol (2000) 0.79

Transgenic expression of soluble human CD5 enhances experimentally-induced autoimmune and anti-tumoral immune responses. PLoS One (2014) 0.78

Mechanisms of transmembrane signalling in human T cell activation. Mol Cell Biochem (1990) 0.78

Determination of the tyrosine phosphorylation sites in the T cell transmembrane glycoprotein CD5. Int Immunol (2001) 0.78